Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Richard Duke to Humans

This is a "connection" page, showing publications Richard Duke has written about Humans.

 
Connection Strength
 
 
 
0.046
 
  1. Haller AA, Lauer GM, King TH, Kemmler C, Fiolkoski V, Lu Y, Bellgrau D, Rodell TC, Apelian D, Franzusoff A, Duke RC. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine. 2007 Feb 09; 25(8):1452-63.
    View in: PubMed
    Score: 0.008
  2. Duke RC. Methods of analyzing chromatin changes accompanying apoptosis of target cells in killer cell assays. Methods Mol Biol. 2000; 121:125-43.
    View in: PubMed
    Score: 0.005
  3. Duke RC, Newell E, Schleicher M, Meech S, Bellgrau D. Transplantation of cells and tissues expressing Fas ligand. Transplant Proc. 1999 May; 31(3):1479-81.
    View in: PubMed
    Score: 0.005
  4. Bellgrau D, Duke RC. Apoptosis and CD95 ligand in immune privileged sites. Int Rev Immunol. 1999; 18(5-6):547-62.
    View in: PubMed
    Score: 0.004
  5. Duke RC, Ojcius DM, Young JD. Cell suicide in health and disease. Sci Am. 1996 Dec; 275(6):80-7.
    View in: PubMed
    Score: 0.004
  6. Duke RC. Apoptosis in cytotoxic T lymphocytes and their targets. Semin Immunol. 1992 Dec; 4(6):407-12.
    View in: PubMed
    Score: 0.003
  7. La Rosa FG, Talmage DW, Zlotnik A, Duke RC. Cellular and molecular immunology of tissue transplantation. Revis Biol Celular. 1988; 17:1-114.
    View in: PubMed
    Score: 0.002
  8. Franzusoff A, Duke RC, King TH, Lu Y, Rodell TC. Yeasts encoding tumour antigens in cancer immunotherapy. Expert Opin Biol Ther. 2005 Apr; 5(4):565-75.
    View in: PubMed
    Score: 0.002
  9. Lu Y, Bellgrau D, Dwyer-Nield LD, Malkinson AM, Duke RC, Rodell TC, Franzusoff A. Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy. Cancer Res. 2004 Aug 01; 64(15):5084-8.
    View in: PubMed
    Score: 0.002
  10. Urquhart JL, Meech SJ, Marr DG, Shellman YG, Duke RC, Norris DA. Regulation of Fas-mediated apoptosis by N-ras in melanoma. J Invest Dermatol. 2002 Sep; 119(3):556-61.
    View in: PubMed
    Score: 0.001
  11. Hedlund TE, Duke RC, Miller GJ. Three-dimensional spheroid cultures of human prostate cancer cell lines. Prostate. 1999 Nov 01; 41(3):154-65.
    View in: PubMed
    Score: 0.001
  12. Srikanth S, Franklin CC, Duke RC, Kraft RS. Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis. Mol Cell Biochem. 1999 Sep; 199(1-2):169-78.
    View in: PubMed
    Score: 0.001
  13. Lin B, Williams-Skipp C, Tao Y, Schleicher MS, Cano LL, Duke RC, Scheinman RI. NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 1999 Jun; 6(6):570-82.
    View in: PubMed
    Score: 0.001
  14. Leon RP, Hedlund T, Meech SJ, Li S, Schaack J, Hunger SP, Duke RC, DeGregori J. Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci U S A. 1998 Oct 27; 95(22):13159-64.
    View in: PubMed
    Score: 0.001
  15. Hedlund TE, Duke RC, Schleicher MS, Miller GJ. Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate. 1998 Jul 01; 36(2):92-101.
    View in: PubMed
    Score: 0.001
  16. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol. 1998 Feb 15; 160(4):1824-30.
    View in: PubMed
    Score: 0.001
  17. Miranda L, Wolf J, Pichuantes S, Duke R, Franzusoff A. Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytes. Proc Natl Acad Sci U S A. 1996 Jul 23; 93(15):7695-700.
    View in: PubMed
    Score: 0.001
  18. Hofer MF, Newell K, Duke RC, Schlievert PM, Freed JH, Leung DY. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis. Proc Natl Acad Sci U S A. 1996 May 28; 93(11):5425-30.
    View in: PubMed
    Score: 0.001
  19. Norris DA, Duke R, Whang K, Middleton M. Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata. J Invest Dermatol. 1995 May; 104(5 Suppl):8S-9S.
    View in: PubMed
    Score: 0.001
  20. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 1992; 10:267-93.
    View in: PubMed
    Score: 0.001
  21. Pettijohn DE, Pfenninger O, Brown J, Duke R, Olsson L. Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells. Proc Natl Acad Sci U S A. 1988 Feb; 85(3):802-6.
    View in: PubMed
    Score: 0.001
  22. Cohen JJ, Duke RC, Chervenak R, Sellins KS, Olson LK. DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system. Adv Exp Med Biol. 1985; 184:493-508.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)